You have 9 free searches left this month | for more free features.

stage IIIB mycosis fungoides/Sezary syndrome

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)

Recruiting
  • Mycosis Fungoides
  • +12 more
  • Pembrolizumab
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV

Recruiting
  • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • +2 more
  • Phoenix, Arizona
  • +11 more
Aug 6, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
Nov 3, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Recruiting
  • Mycosis Fungoides
  • Non-Hodgkin's Lymphoma
    • Duarte, California
    • +12 more
    Jun 17, 2022

    Mapping Emotional Dynamics During Corticosteroid Treatment

    Recruiting
    • Emotions
    • Corticosteroids
    • Short daily questionnaire
    • Leiden, Zuid-Holland, Netherlands
      LUMC
    Aug 30, 2022

    Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

    Active, not recruiting
    • Mycosis Fungoides
    • +2 more
    • Graz, Austria
    • +53 more
    Dec 12, 2022

    CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)

    Recruiting
    • CTCL
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    May 18, 2023

    Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Fungoides Mycosis Sezary Syndrome
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Jul 13, 2023

    Patients With Mycosis Fungoides and Sézary Syndrome.

    Recruiting
    • Mycosis Fungoides
    • Sezary Syndrome
    • Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
    • Lund, Sweden
      Lund University Hospital
    May 21, 2021

    Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

    Recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Durvalumab
    • +2 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

    Withdrawn
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides/Sezary Syndrome
    • Zürich, Switzerland
      UniversitaetsSpital Zurich - Division of Dermatology
    Aug 31, 2021

    Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

    Terminated
    • Mycosis Fungoides
    • +2 more
    • Naloxone Hydrochloride Lotion, 0.5%
    • Placebo Lotion
    • Little Rock, Arkansas
    • +15 more
    Oct 26, 2022

    Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

    Terminated
    • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
    • +13 more
    • Chicago, Illinois
      Northwestern University
    Jul 24, 2019

    Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

    Completed
    • Cutaneous T Cell Lymphoma
    • +2 more
    • Leeds, United Kingdom
      Covance Clinical research Unit Ltd.
    Feb 3, 2022

    Poteligeo in Adult Patients With MF and SS (PROSPER)

    Not yet recruiting
    • Mycosis Fungoides and Sézary Syndrome
    • Saint Louis, Missouri
    • +15 more
    Jul 8, 2022